Skip to main content
Equibles

David J. Lennon

CEO

Whitehawk Therapeutics, Inc. (WHWK)

Board Member

Whitehawk Therapeutics, Inc. (WHWK)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David J. Lennon

David J. Lennon is recorded as CEO and Board Member at Whitehawk Therapeutics, Inc. (WHWK). Whitehawk Therapeutics, Inc. reported in an 8-K filed October 2, 2023 that David J. Lennon was appointed Class II director, effective October 2, 2023. Whitehawk Therapeutics, Inc. reported in an 8-K filed October 2, 2023 that David J. Lennon was appointed President and Chief Executive Officer, effective October 2, 2023.

“On September 27, 2023, the Board increased the Board's size from eight (8) to nine (9) directors and appointed Dr. Lennon to fill the resulting vacancy, effective as of the Effective Date.”
Whitehawk Therapeutics, Inc. Form 8-K, filed October 2, 2023 · Read the filing
“On September 27, 2023, the Board of Directors (the "Board") of Aadi Bioscience, Inc. (the "Company") appointed David J. Lennon, Ph.D., to serve as the Company's President and Chief Executive Officer and principal executive officer, effective as of October 2, 2023 (the "Effective Date"), replacing Scott Giacobello in such roles.”
Whitehawk Therapeutics, Inc. Form 8-K, filed October 2, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Whitehawk Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.